CSI Market
Sign In | Register

Ligand Pharmaceuticals Incorporated (LGND) Annual Balance Sheets

Annual · GAAP · USD millions
Access LGND quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Ligand Pharmaceuticals Incorporated's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent174.93
Short-term Investments, Total558.59
Cash & Short-term Investments732.00
Accounts receivable59.60
Income Taxes Receivable, Current NO1.45
Inventories9.13
Other Current Assets28.58
Prepaid Expense, Current AS0.00
Total Current Assets832.27
Equipment/Property/Plant Net0.00
Goodwill net101.54
Intangible Assets225.44
Long-term investments121.45
Derivative Asset, Noncurrent DE115.63
Deferred Tax Assets, Net, Noncurrent AS0.00
Other Assets, Noncurrent385.76
Total Assets1,560.64
Liabilities
Accounts Payable, Current AC3.24
Accrued Liabilities, Current AC31.45
Convertible Debt, Current LO0.00
Other Liabilities, Current1.52
Taxes Payable, Current, Total1.24
Total Current Liabilities37.45
Long-term debt446.19
Convertible Debt, Noncurrent LO0.00
Total Long-term Debt446.19
Deferred Revenue, Noncurrent DE0.00
Deferred Tax Liabilities, Net, Noncurrent LI0.00
Other liabilities, Noncurrent59.79
Current Portion Of Liability For Contingent Value Rights0.29
Liability For Contingent Value Rights2.93
Total Liabilities543.43
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock400.65
Retained Earnings / Accumulated Deficit608.09
Accumulated Other Comprehensive Income0.00
Other Equity8.46
Common Stockholder's Equity1,017.21
Total Stockholder's Equity1,017.21
Liabilities & Stockholder's Equity1,560.64
4 historic quarters locked

Sign in to unlock the full Ligand Pharmaceuticals Incorporated balance sheet history.

Sign In Create Free Account

About Ligand Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 27, 2026
  • Source: lgnd-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000886163-26-000006

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License